$1.51
0.06354.38%
At close: May 7, 5:00 PM EST
$1.38
-0.07-4.83%
Pre-Market: 7:29 AM EST
Apimeds Pharmaceuticals Us Inc Earnings Estimates
APUSAMEX
Earnings: Q4 2025 Earnings were released on Mon May 4th, before the market open
Apimeds Pharmaceuticals Earnings Estimates, EPS & Revenue | AMEX:APUS
Apimeds Pharmaceuticals (APUS) is scheduled to report Q1 earnings on May 22, 2026.
Earnings Date
May 4
EPS
$-0.800
Quarterly Revenue
$0.00
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Apimeds Pharmaceuticals Earnings History
Analyze the earnings history of Apimeds Pharmaceuticals using advanced sorting and filters.
Loading calendar...
Apimeds Pharmaceuticals (APUS) Earnings Per Share
The chart below shows Apimeds Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.
Apimeds Pharmaceuticals (APUS) Revenue
The chart below shows Apimeds Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Apimeds Pharmaceuticals (AMEX:APUS) reporting earnings?
Apimeds Pharmaceuticals (APUS) is scheduled to report earnings on May 22, 2026. The last reported earnings were for reported on May 4, 2026 for Q4.
What were the latest earnings per share (EPS) for Apimeds Pharmaceuticals (AMEX:APUS)?
The Actual EPS was $-0.80, which missed the estimate of $0.00.
What were Apimeds Pharmaceuticals’s (AMEX:APUS) revenues?
The Actual Revenue was $0.00, which hit the estimate of $0.00.
